Cargando…

Lack of Genetic Associations of PPAR-γ and PGC-1α with Alzheimer's Disease and Parkinson's Disease with Dementia

BACKGROUND AND AIMS: Similar clinical and pathological features have been observed in Alzheimer's disease (AD) and Parkinson's disease with dementia (PDD). Both the peroxisome proliferator-activated receptor-γ (PPAR-γ) gene and the peroxisome proliferator-activated receptor-γ coactivator-1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shibata, Nobuto, Motoi, Yumiko, Tomiyama, Hiroyuki, Ohnuma, Tohru, Kuerban, Bolati, Tomson, Katrin, Komatsu, Miwa, Shimazaki, Hiromi, Hattori, Nobutaka, Arai, Heii
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2013
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670632/ https://www.ncbi.nlm.nih.gov/pubmed/23741228 http://dx.doi.org/10.1159/000351419

Ejemplares similares

Genetic Association between Akt1 Polymorphisms and Alzheimer's Disease in a Japanese Population
por: Shibata, Nobuto, et al.
Publicado: (2011)

Age-Related Association between Apolipoprotein E ε4 and Cognitive Function in Japanese Patients with Alzheimer's Disease
por: Nagata, Tomoyuki, et al.
Publicado: (2013)

Genetic Association between Neurotrophin-3 Polymorphisms and Alzheimer's Disease in Japanese Patients
por: Nagata, Tomoyuki, et al.
Publicado: (2013)

No Associations Found between PGBD1 and the Age of Onset in Japanese Patients Diagnosed with Sporadic Alzheimer's Disease
por: Ohnuma, Tohru, et al.
Publicado: (2012)

Association between DNA Methylation of the BDNF Promoter Region and Clinical Presentation in Alzheimer's Disease
por: Nagata, Tomoyuki, et al.
Publicado: (2015)

Genetic Association between Presenilin 2 Polymorphisms and Alzheimer's Disease and Dementia of Lewy Body Type in a Japanese Population
por: Suzuki, Ayako, et al.
Publicado: (2016)

Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer’s disease: a prospective, open-label pilot study
por: Ohnuma, Tohru, et al.
Publicado: (2016)

Genetic or Psychogenic? A Case Study of “Folie à Quatre” Including Twins
por: Ohnuma, Tohru, et al.
Publicado: (2015)

Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer’s Disease and Amnesic Mild Cognitive Impairment
por: Kobayashi, Nobuyuki, et al.
Publicado: (2016)

Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer’s Disease and Amnestic Mild Cognitive Impairment
por: Kobayashi, Nobuyuki, et al.
Publicado: (2016)

Carbonyl Stress and Microinflammation-Related Molecules as Potential Biomarkers in Schizophrenia
por: Ohnuma, Tohru, et al.
Publicado: (2018)

Supplementation with Matured Hop Bitter Acids Improves Cognitive Performance and Mood State in Healthy Older Adults with Subjective Cognitive Decline
por: Fukuda, Takafumi, et al.
Publicado: (2020)

PPARγ and PGC-1α as Therapeutic Targets in Parkinson’s
por: Corona, Juan Carlos, et al.
Publicado: (2014)

Novel Variants in the CLCN1, RYR2, and DCTN1 Found in Elderly Japanese Dementia Patients: A Case Series
por: Hori, Atsushi, et al.
Publicado: (2021)

Donepezil may reduce the risk of comorbidities in patients with Alzheimer's disease: A large-scale matched case-control analysis in Japan
por: Kobayashi, Hiroyuki, et al.
Publicado: (2018)

Relationship between cognitive impairment and white-matter alteration in Parkinson’s disease with dementia: tract-based spatial statistics and tract-specific analysis
por: Kamagata, Koji, et al.
Publicado: (2013)

The effect of Chinese herbs and its effective components on coronary heart disease through PPARs-PGC1α pathway
por: Wang, Qiyan, et al.
Publicado: (2016)

High-fat diet–induced activation of SGK1 promotes Alzheimer’s disease–associated tau pathology
por: Elahi, Montasir, et al.
Publicado: (2021)

PXR Suppresses PPARα-Dependent HMGCS2 Gene Transcription by Inhibiting the Interaction between PPARα and PGC1α
por: Shizu, Ryota, et al.
Publicado: (2021)

PGC-1α Protects against Hepatic Ischemia Reperfusion Injury by Activating PPARα and PPARγ and Regulating ROS Production
por: Wang, Chaoqun, et al.
Publicado: (2021)

Marked Reduction in the Striatal Dopamine Transporter Uptake During the Early Stage of Motor Symptoms in Patients with the MAPT N279K Mutation
por: Takeshige, Haruka, et al.
Publicado: (2018)

The PPAR [Formula: see text]-PGC-1 [Formula: see text] Axis Controls Cardiac Energy Metabolism in Healthy and Diseased Myocardium
por: Duncan, Jennifer G., et al.
Publicado: (2008)

PGC-1s in the Spotlight with Parkinson’s Disease
por: Piccinin, Elena, et al.
Publicado: (2021)

LncRNA SNHG10 suppresses the development of doxorubicin resistance by downregulating miR-302b in triple-negative breast cancer
por: Aini, Shataer, et al.
Publicado: (2022)

Palmitate-induced Regulation of PPARγ via PGC1α: a Mechanism for Lipid Accumulation in the Liver in Nonalcoholic Fatty Liver Disease
por: Maruyama, Hitoshi, et al.
Publicado: (2016)

Aspirin Improves Nonalcoholic Fatty Liver Disease and Atherosclerosis through Regulation of the PPARδ-AMPK-PGC-1α Pathway in Dyslipidemic Conditions
por: Han, Yoon-Mi, et al.
Publicado: (2020)

ATGL-Catalyzed Lipolysis Regulates SIRT1 to Control PGC-1α/PPAR-α Signaling
por: Khan, Salmaan Ahmed, et al.
Publicado: (2015)

Resveratrol enhances HBV replication through activating Sirt1-PGC-1α-PPARα pathway
por: Shi, Yixian, et al.
Publicado: (2016)

MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα
por: Yin, Zhongwei, et al.
Publicado: (2019)

Muscle Injuries Induce a Prostacyclin‐PPARγ/PGC1a‐FAO Spike That Boosts Regeneration
por: Luo, Lanfang, et al.
Publicado: (2023)

Cholecystokinin Octapeptide Promotes ANP Secretion through Activation of NOX4–PGC-1α–PPARα/PPARγ Signaling in Isolated Beating Rat Atria
por: Han, Zhuo-na, et al.
Publicado: (2022)

Design and Development of Novel Glitazones for Activation of PGC-1α Signaling Via PPAR-γ Agonism: A Promising Therapeutic Approach against Parkinson’s Disease
por: Prabhakaran, Prabitha, et al.
Publicado: (2023)

Huoxue Huatan Decoction Ameliorates Myocardial Ischemia/Reperfusion Injury in Hyperlipidemic Rats via PGC-1α–PPARα and PGC-1α–NRF1–mtTFA Pathways
por: Lin, Fei, et al.
Publicado: (2020)

Nobiletin Attenuates Pathological Cardiac Remodeling after Myocardial Infarction via Activating PPARγ and PGC1α
por: Zhou, Yufei, et al.
Publicado: (2021)

PERM1 regulates genes involved in fatty acid metabolism in the heart by interacting with PPARα and PGC-1α
por: Huang, Chun-yang, et al.
Publicado: (2022)

Stemness of Normal and Cancer Cells: The Influence of Methionine Needs and SIRT1/PGC-1α/PPAR-α Players
por: Siblini, Youssef, et al.
Publicado: (2022)

PGC−1α Promoter Methylation in Parkinson’s Disease
por: Su, Xiaomin, et al.
Publicado: (2015)

The association between PGC-1α and Alzheimer's disease
por: Sweeney, Gary, et al.
Publicado: (2016)

PPARs in Alzheimer's Disease
por: Kummer, Markus P., et al.
Publicado: (2008)

PPARs in Viral Disease
por: Capeau, Jacqueline, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_07j4j24t28rle6tmpkp64osms1